A detailed history of Signature Estate & Investment Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Signature Estate & Investment Advisors LLC holds 327 shares of REGN stock, worth $231,355. This represents 0.01% of its overall portfolio holdings.

Number of Shares
327
Previous 298 9.73%
Holding current value
$231,355
Previous $313,000 25.88%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$701.85 - $1046.91 $20,353 - $30,360
29 Added 9.73%
327 $232,000
Q3 2024

Nov 06, 2024

BUY
$1024.09 - $1201.76 $305,178 - $358,124
298 New
298 $313,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Signature Estate & Investment Advisors LLC Portfolio

Follow Signature Estate & Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Estate & Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Estate & Investment Advisors LLC with notifications on news.